SODIUM FLUORIDE F 18 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Fluoride F 18, and when can generic versions of Sodium Fluoride F 18 launch?
Sodium Fluoride F 18 is a drug marketed by Nih Nci Dctd and is included in one NDA.
The generic ingredient in SODIUM FLUORIDE F 18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Fluoride F 18
A generic version of SODIUM FLUORIDE F 18 was approved as sodium fluoride f-18 by MCPRF on June 28th, 2013.
Summary for SODIUM FLUORIDE F 18
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 116 |
Patent Applications: | 10 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM FLUORIDE F 18 at DailyMed |
Recent Clinical Trials for SODIUM FLUORIDE F 18
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. D. Y. Patil Dental College & Hospital | Phase 3 |
Jasberry Healthcare Pvt. Ltd | Phase 3 |
HALEON | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM FLUORIDE F 18
US Patents and Regulatory Information for SODIUM FLUORIDE F 18
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nih Nci Dctd | SODIUM FLUORIDE F 18 | sodium fluoride f-18 | INJECTABLE;INTRAVENOUS | 022494-001 | Jan 26, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |